Simplyhealth has appointed Paul Schreier as its new chief executive.
Schreier will assume the role of CEO in mid-May, pending regulatory approval, succeeding Acting CEO Nicholas Potter, who will resume his position as chief financial officer.
Schreier has a wealth of expertise, having held the position of Interim CEO at the Wellcome Trust, where he oversaw work on Covid-19 treatment and was appointed global therapeutics co-lead for the World Health Organisation’s accelerated Covid tools cooperation. He most recently served as chief executive at Hakluyt since 2016.
Schreier says: “I am absolutely delighted to be joining Simplyhealth. I believe that we have an amazing opportunity to make a difference to the health of people across the UK, which is something I feel passionately about. I am very much looking forward to leading the company at this pivotal time in our country’s history, when improving access to healthcare has never been more important.”
Simplyhealth chairman Mike Hall says: “I would like to take this opportunity to publicly thank Nick for stepping up and taking on the role of Acting CEO over the past twelve months, and with the help of all of our colleagues continuing to transform the business to be better delivering low-cost, accessible, quality healthcare for our customers.
“Paul has a truly impressive professional background and through the recruitment process all parties agreed there was a strong strategic and cultural alignment which we believe makes him exceptionally well placed to lead Simplyhealth in delivering on our ambitious future plans.”
